Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioTheranostics

Request full access

Extensive research generates high-complexity molecular tools that help physicians execute more informed treatment decisions

San Diego, United StatesFounded 1996Biotech & Life Sciences

About BioTheranostics

Biotheranostics, headquartered in San Diego, CA, specializes in genomic testing for oncology, focusing on breast and metastatic cancers. The company offers proprietary genomic assays, such as the Breast Cancer Index, which is the only test recognized by both the ASCO and NCCN Clinical Practice Guidelines. These tests help predict the benefit of extended endocrine therapy in hormone receptor-positive, early-stage breast cancer, and identify tumor types and subtypes in metastatic cancer patients with unclear diagnoses. Acquired by Hologic in February 2021, Biotheranostics continues to support personalized disease management in oncology. The company primarily serves oncologists and healthcare providers, operating within the precision medicine market. Biotheranostics generates revenue through the sale of its genomic tests, which are used to guide treatment decisions and improve patient outcomes.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
1996
Headquarters
San Diego, United States
Employees
97
Open positions
None listed
Dealroom signal
32.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Testing, Risk Management, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Feb 2021 $230M $230M Hologic ↗
GROWTH EQUITY VC✓Equity / VC Jan 2016 $32M — Evidity Health Capital · MVM Life Science Partners · HealthQuest Capital —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

BioTheranostics website traffic

Latest recorded traffic for BioTheranostics is 240 monthly website visits, down 36.8% over the last three months. BioTheranostics's team declined 16.4% over the past year.

Latest monthly visits240 3-month web change-36.8% 1-year team growth-16.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BioTheranostics in the San Diego ecosystem

Live from Dealroom

The BioTheranostics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later3 investors entered at this stage

  • Evidity Health Capital
  • MVM Life Science Partners
  • HealthQuest Capital

Other known investors2 additional known investors

  • BioMérieux
  • Hologic
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioTheranostics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioTheranostics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.